Equity Profile

COLL

Collegium Pharmaceutical, Inc.

Health CarePharmaceuticals$1.1B

Aug4Thu

Post-Earnings Recap

ReportedQ2-2022After Close4:01 PM EDT

Collegium Pharmaceutical Misses on EPS, Stock Up 2.55%

Metric	Actual	Expected	Surprise
EPS	$-0.15	N/A	-113.00%
Revenue	N/A	N/A	N/A

management commentary, guidance changes, and full analysis available with Pro.

Collegium Pharmaceutical Misses on EPS, Stock Up 2.55%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$-0.15	N/A	-113.00%
Revenue	N/A	N/A	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

Collegium Pharmaceutical reported a loss per share of $0.15, significantly missing expectations. Despite the earnings miss, the stock reacted positively, rising 2.55%. This increase may reflect investor optimism or other market factors unrelated to the earnings report.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug1

FANGReported

Diamondback Energy, Inc.

RecapView

Aug1

MPWRReported

Collegium Pharmaceutical Misses on EPS, Stock Up 2.55%

Metric	Actual	Expected	Surprise
EPS	$-0.15	N/A	-113.00%
Revenue	N/A	N/A	N/A

management commentary, guidance changes, and full analysis available with Pro.

Collegium Pharmaceutical Misses on EPS, Stock Up 2.55%

Key Numbers

Metric	Actual	Expected	Surprise
EPS	$-0.15	N/A	-113.00%
Revenue	N/A	N/A	N/A

Management Commentary

Tone: Unknown

No transcript is on record, and the analysis is based on numerical results only.

What It Means

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime